Clinical Trial Update: A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating Carboxypeptidase-G2 (glucarpidase) with thymidine to treat methotrexate toxicity in patients with renal dysfunction; the study is compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Diseases

Drugs mentioned

• Carboxypeptidase-G2 (glucarpidase)
• Thymidine (2'-deoxythymidine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kidney Diseases | Phase 1 | Status: COMPLETED